Better Therapeutics, Inc. (BTTX)
OTCMKTS: BTTX · Delayed Price · USD
0.0129
-0.0008 (-5.84%)
Mar 27, 2024, 3:49 PM EDT - Market closed

Better Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Net Income
-39.76-40.34-6.39-5.8
Depreciation & Amortization
2.731.620.080.07
Share-Based Compensation
1.820.650.230.08
Other Operating Activities
6.287.250.31-0.58
Operating Cash Flow
-28.93-30.82-5.77-6.22
Capital Expenditures
-1.18-1.07-2.31-2.74
Investing Cash Flow
-1.18-1.07-2.31-2.74
Common Stock Issued
0.26-14.8700
Other Financing Activities
5.0387.27.458.7
Financing Cash Flow
5.2872.337.458.7
Net Cash Flow
-24.8340.44-0.63-0.25
Free Cash Flow
-30.11-31.89-8.08-8.95
Free Cash Flow Margin
---100987.50%-49738.89%
Free Cash Flow Per Share
-1.28-2.46-0.34-0.38
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.